Stamford, CT -- (SBWIRE) -- 01/11/2014 -- Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: J.C. Penney Company, Inc. (NYSE:JCP), DryShips Inc. (NASDAQ:DRYS), MannKind Corporation (NASDAQ:MNKD), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)
J.C. Penney Company, Inc. (NYSE:JCP) opened the session at $7.59, trading in a range of $7.33 - $7.60. The stock showed a negative performance of -3.93% in the last trading session from its previous close of $7.64 and closed at $7.34. The stock traded on a volume of 25.67 million shares and the average volume of the stock remained 31.34 million shares. J. C. Penney Company, Inc. is a holding company whose principal operating subsidiary is J. C. Penney Corporation, Inc. (JCP). The Company’s business consists of selling merchandise and services to consumers through its department stores and through its Internet Website at jcp.com. As of February 2, 2013, the Company operated 1,104 department stores throughout the continental United States, Alaska and Puerto Rico, of which 429 were owned, including 123 stores located on ground leases.
Has JCP Found The Bottom and Ready To Move Up? Find Out Here
DryShips Inc. (NASDAQ:DRYS) traded 25.14 million shares in the last business day while the average volume of the stock remained 16.65 million shares. The stock showed a negative movement of -1.53% to end at $3.86. The 52 week range of the stock remained $1.65 - $5.00. DryShips Inc. (DryShips) is a holding company engaged in the ocean transportation services of drybulk cargoes and crude oil worldwide through the ownership and operation of drybulk carrier vessels and oil tankers and offshore drilling services through the ownership and operation of ultra-deepwater drilling units. As of December 31, 2011, it owned and operated two fifth generation ultra-deepwater, semi-submersible offshore drilling rigs, the Leiv Eiriksson and the Eirik Raude, and four sixth generation, advanced capability ultra-deepwater drillships, the Ocean Rig Corcovado, the Ocean Rig Olympia, the Ocean Rig Poseidon and the Ocean Rig Mykonos.
Has DRYS Found The Bottom And Ready To Gain Momentum? Find Out Here
MannKind Corporation (NASDAQ:MNKD) reported 23.60 million shares were exchanged during the last trade, while the average volume is about 5.71 million shares. The stock dropped -16.38% and finished the day at $5.92. The beta of the stock is recorded at 1.87. MannKind Corporation (MannKind) is a development-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. The Company’s product candidate, AFREZZA (insulin human) inhalation powder, is insulin that is in late-stage clinical investigation for the treatment of adults with type I or type II diabetes for the control of hyperglycemia.
Why Should Investors Buy MNKD After the Recent Fall? Just Go Here and Find Out
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares dropped -0.46 percent from its previous close of $6.76 to close at $6.73. Traded with volume of 15.02 million shares in the prior session and the average volume of the stock remained 33.25 million shares. ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. ARIAD’s first medicine, Iclusig, is approved in the United States for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia that is resistant or intolerant to prior TKI therapy.
Will ARIA Get Buyers Even After The Recent Rally? Find Out Here
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Our Penny Stock Newsletter also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Read full disclaimer at: http://www.jetlifepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)